Net Loss Per Common Share (Details) - Schedule of potentially anti-dilutive shares - shares	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Schedule of potentially anti-dilutive shares [Abstract]
Stock options issued and outstanding	1,870,245	1,415,789
Restricted stock units issued and outstanding	474,913	384,994
Conversion of Series 1 Convertible Preferred Stock	8,029,039	8,029,039
Total potentially dilutive shares	10,374,197	9,829,822